Why is Indrayani Biotec falling/rising?

As of 04-Jul, Indrayani Biotech Ltd's stock price is currently at 15.75, reflecting a decrease of 0.16 or 1.01%. The stock has experienced a trend reversal, falling after five consecutive days of gains. Despite this recent decline, the stock has shown a strong performance over the past week with a return of 13.31%, although it has underperformed in the longer term, with a staggering 72.88% loss over the past year. The company has reported operating losses and a weak long-term fundamental strength, highlighted by a high Debt to EBITDA ratio of 9.25 times and a significant drop in profits of 134.9%. Additionally, institutional investors have reduced their stakes, indicating a lack of confidence in the company's future prospects.
In the broader market context, the Sensex has gained 3.01% over the past month, contrasting with Indrayani Biotech's decline of 3.20% during the same period. This underperformance relative to the benchmark reflects the company's ongoing challenges, including negative results for the last four consecutive quarters and a low return on capital employed (ROCE) of 2.87%. While the stock is trading at a discount compared to its peers, the overall sentiment remains cautious due to its weak fundamentals and falling participation from institutional investors, which could further pressure the stock price in the near term.